Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Generalizable stratification based on thalamo-somatomotor functional connectivity predicts responses to antidepressants in patients with depression

by jlohrconsulting | Sep 21, 2025 | Uncategorized

Mol Psychiatry. 2025 Sep 20. doi: 10.1038/s41380-025-03224-5. Online ahead of print. ABSTRACT Major depressive disorder (MDD) is diagnosed based on signs and symptoms without relying on physical, biological, or cognitive tests. Patients with MDD exhibit a wide range...

Irisin/BDNF pathway dysfunction subserves Anorexia Nervosa pathophysiology

by jlohrconsulting | Sep 21, 2025 | Uncategorized

Pharmacol Res. 2025 Sep 18:107959. doi: 10.1016/j.phrs.2025.107959. Online ahead of print. ABSTRACT Patients with Anorexia Nervosa (AN) often exhibit a heightened sense of reward associated with self-imposed starvation and excessive exercise in their pursuit of weight...

Misleading EEG in CACNA1A mutation: A case of late-onset episodic ataxia type 2

by jlohrconsulting | Sep 21, 2025 | Uncategorized

Parkinsonism Relat Disord. 2025 Sep 16:108051. doi: 10.1016/j.parkreldis.2025.108051. Online ahead of print. ABSTRACT BACKGROUND: Episodic ataxia type 2 (EA2) is a rare, autosomal dominant paroxysmal neurological disorder caused by mutations in the CACNA1A gene. Its...

Remimazolam use in obstetric patients: a single-center retrospective study (2021-2024)

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Int J Obstet Anesth. 2025 Aug 8;64:104750. doi: 10.1016/j.ijoa.2025.104750. Online ahead of print. ABSTRACT BACKGROUND: Remimazolam is an ultra-short-acting intravenous benzodiazepine approved for procedural sedation and general anaesthesia. Its favourable...

Ketamine/esketamine in the treatment of depression with comorbid borderline personality disorder or traits: A systematic review of effectiveness

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Aust N Z J Psychiatry. 2025 Sep 20:48674251374472. doi: 10.1177/00048674251374472. Online ahead of print. ABSTRACT INTRODUCTION: There is mounting evidence for the use of ketamine/esketamine in the treatment of depression. This paper examines how comorbid borderline...

Natural Language Response Formats for Assessing Depression and Worry With Large Language Models: A Sequential Evaluation With Model Pre-Registration

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Assessment. 2025 Sep 20:10731911251364022. doi: 10.1177/10731911251364022. Online ahead of print. ABSTRACT Large language models can transform individuals’ mental health descriptions into scores that correlate with rating scales approaching theoretical upper...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments